Gilder Gagnon Howe & Co’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-144,476
| Closed | -$17.1M | – | 298 |
|
|
2022
Q1 | $17.1M | Sell |
144,476
-114,021
| -44% | -$13.5M | 0.16% | 117 |
|
|
2021
Q4 | $35.6M | Buy |
258,497
+8,371
| +3% | +$1.15M | 0.2% | 106 |
|
|
2021
Q3 | $34.7M | Sell |
250,126
-112
| -0% | -$15.6K | 0.18% | 123 |
|
|
2021
Q2 | $24.3M | Sell |
250,238
-13,182
| -5% | -$1.28M | 0.12% | 148 |
|
|
2021
Q1 | $18M | Buy |
263,420
+162,113
| +160% | +$11.1M | 0.1% | 164 |
|
|
2020
Q4 | $8.68M | Sell |
101,307
-464
| -0.5% | -$39.8K | 0.04% | 193 |
|
|
2020
Q3 | $6.62M | Sell |
101,771
-581
| -0.6% | -$37.8K | 0.04% | 184 |
|
|
2020
Q2 | $7.48M | Buy |
102,352
+193
| +0.2% | +$14.1K | 0.06% | 161 |
|
|
2020
Q1 | $3.48M | Buy |
+102,159
| New | +$3.48M | 0.04% | 157 |
|
|
2017
Q4 | – | Sell |
-74,637
| Closed | -$2.79M | – | 318 |
|
|
2017
Q3 | $2.79M | Sell |
74,637
-2,532
| -3% | -$94.6K | 0.04% | 176 |
|
|
2017
Q2 | $1.93M | Buy |
+77,169
| New | +$1.93M | 0.03% | 185 |
|